콘텐츠로 건너뛰기
Merck
  • Pilot in vivo toxicological investigation of boron nitride nanotubes.

Pilot in vivo toxicological investigation of boron nitride nanotubes.

International journal of nanomedicine (2012-01-26)
Gianni Ciofani, Serena Danti, Giada Graziana Genchi, Delfo D'Alessandro, Jean-Luc Pellequer, Michaël Odorico, Virgilio Mattoli, Mario Giorgi
초록

Boron nitride nanotubes (BNNTs) have attracted huge attention in many different research fields thanks to their outstanding chemical and physical properties. During recent years, our group has pioneered the use of BNNTs for biomedical applications, first of all assessing their in vitro cytocompatibility on many different cell lines. At this point, in vivo investigations are necessary before proceeding toward realistic developments of the proposed applications. In this communication, we report a pilot toxicological study of BNNTs in rabbits. Animals were injected with a 1 mg/kg BNNT solution and blood tests were performed up to 72 hours after injection. The analyses aimed at evaluating any acute alteration of hematic parameters that could represent evidence of functional impairment in blood, liver, and kidneys. Even if preliminary, the data are highly promising, as they showed no adverse effects on all the evaluated parameters, and therefore suggest the possibility of the realistic application of BNNTs in the biomedical field.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Glycol chitosan, ≥60% (titration), crystalline